Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Maternal Depression and Opioid Use After Cesarean Delivery.

Obstetrics and gynecology·2026

Same author

Cesarean Anesthesia Type and Neonatal Outcomes: Comment.

Anesthesiology·2026

Same author

Pain during Cesarean Delivery with Neuraxial Anesthesia: Have We Made Any Progress?

Anesthesiology·2026

Same author

Responsible use of large language models in manuscript authorship, peer review, and editorial processes: a Delphi consensus among editors-in-chief of anaesthesia and pain medicine journals (RULE-AP).

British journal of anaesthesia·2026

Same author

Childhood sexual abuse and post-cesarean pain.

Pregnancy (Hoboken, N.J.)·2026

Same author

Selective nonreporting of 5-min Apgar scores and its safety assessment of out-of-hospital births: a population-based study of United States' birth data, 2016-2023 a population based study.

Lancet regional health. Americas·2026

Same journal

Reimagining cardiac surgery-the emerging role of prehabilitation and risk optimization.

Best practice & research. Clinical anaesthesiology·2026

Same journal

Prehabilitation and enhanced recovery after cardiac surgery.

Best practice & research. Clinical anaesthesiology·2026

Same journal

The role of biomarkers in the preoperative evaluation of cardiac surgical patients - A narrative review.

Best practice & research. Clinical anaesthesiology·2026

Same journal

Magic in a bottle? A Focused review of factor concentrates for the intraoperative treatment of acquired coagulopathy - Fibrinogen concentrate, prothrombin complex concentrate, and recombinant activated factor VII.

Best practice & research. Clinical anaesthesiology·2025

Same journal

ESAs in perioperative anemia management: Who, what, how and why?

Best practice & research. Clinical anaesthesiology·2025

Same journal

Does patient blood management represent good value for money?

Best practice & research. Clinical anaesthesiology·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 28, 2026

The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster

The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster

Published on: February 24, 2023

Pharmacogenetics in obstetric anesthesia.

Ruth Landau¹, Richard Smiley²

¹Columbia University Medical Center, Center for Precision Medicine, Department of Anesthesiology, Columbia University College of Physicians & Surgeons, 630 West 168th St PH-5 (5th Floor Office PH-546, 11th Floor Office CHN-1118), New York, NY 10032, USA.

Best Practice & Research. Clinical Anaesthesiology

|June 20, 2017

Summary

This summary is machine-generated.

Genetic research in obstetrics and anesthesiology is exploring gene variants for conditions like preterm labor and pain. While current findings show modest effects, future technologies may enhance clinical applications.

Keywords:

ADRB2 CYP2D6 OPRM1 analgesia cesarean delivery ephedrine genetics labor opioids pain pharmacogenetics polymorphisms

More Related Videos

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Related Experiment Videos

Last Updated: Feb 28, 2026

The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster

The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster

Published on: February 24, 2023

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Area of Science:

Obstetrics and Gynecology
Anesthesiology
Genetics
Pharmacogenomics

Background:

The 21st century is characterized by the rise of precision medicine, leveraging genetic insights for tailored therapies.
Genetic investigations in obstetrics and anesthesiology aim to understand biological pathways and develop novel drug therapies.
Key areas include preterm labor, spinal anesthesia-induced hypotension, and pain/analgesic responses.

Purpose of the Study:

To review the current state of genetic investigations in obstetrics and obstetric anesthesiology.
To identify the impact of genetic variations on clinical outcomes and therapeutic responses.
To project the future influence of advanced genetic technologies in these fields.

Main Methods:

Review of studies investigating single nucleotide polymorphisms (SNPs) related to obstetric and anesthesiology conditions.
Analysis of genetic effects on preterm labor, labor progression, hypotension, and pain perception.
Exploration of emerging technologies like whole exome/genome sequencing and real-time genotyping.

Main Results:

Most studies have focused on specific SNPs, revealing modest effects of genetic variation.
Current genetic findings have not yet significantly impacted clinical practice in obstetrics and anesthesiology.
Limited tangible impact on current clinical practice observed.

Conclusions:

While genetic variations show modest effects, their clinical impact in obstetrics and anesthesiology is currently limited.
Advancements in sequencing, big data, and genotyping technologies are poised to increase the role of genetics.
Future integration of genetic information may personalize treatment and improve patient outcomes in obstetric anesthesia.